Pharmacogenomics and Personalized Medicine: Bridging Genetic Knowledge and Clinical Practice

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework* Clinical Pharmacology & Therapeutics. ,vol. 69, pp. 89- 95 ,(2001) , 10.1067/MCP.2001.113989

Heather J Ribaudo, Catia Marzolini, Todd Hulgan, David B Clifford, Richard B Kim, Edward P Acosta, Roy M Gulick, David W Haas, Camlin Tierney, Grant R Wilkinson, Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS. ,vol. 18, pp. 2391- 2400 ,(2004)

B??rbara Arias, Rosa Catal??n, Crist??bal Gast??, Blanca Guti??rrez, Lourdes Fa??an??s, 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. Journal of Clinical Psychopharmacology. ,vol. 23, pp. 563- 567 ,(2003) , 10.1097/01.JCP.0000095350.32154.73

TE Klein, RB Altman, Niclas Eriksson, BF Gage, SE Kimmel, MT Lee, NA Limdi, D Page, DM Roden, MJ Wagner, MD Caldwell, JA Johnson, YT Chen, MS Wen, Y Caraco, I Achache, S Blotnick, M Muszkat, JG Shin, HS Kim, G Suarez-Kurtz, JA Perini, E Silva-Assuncao, JL Anderson, BD Horne, JF Carlquist, RL Berg, JK Burmester, BC Goh, SC Lee, F Kamali, E Sconce, AK Daly, AH Wu, TY Langaee, H Feng, L Cavallari, K Momary, M Pirmohamed, A Jorgensen, CH Toh, P Williamson, H McLeod, JP Evans, KE Weck, C Brensinger, Y Nakamura, T Mushiroda, D Veenstra, L Meckley, MJ Rieder, AE Rettie, M Wadelius, H Melhus, CM Stein, U Schwartz, D Kurnik, E Deych, P Lenzini, C Eby, LY Chen, P Deloukas, A Motsinger-Reif, H Sagreiya, BS Srinivasan, E Lantz, T Chang, M Ritchie, LS Lu, Estimation of the warfarin dose with clinical and pharmacogenetic data The New England Journal of Medicine. ,vol. 360, pp. 753- 764 ,(2009) , 10.1056/NEJMOA0809329

S. S.-J. Lee, A. Mudaliar, Racing Forward: The Genomics and Personalized Medicine Act Science. ,vol. 323, pp. 342- 342 ,(2009) , 10.1126/SCIENCE.1165768

John A. Robertson, Consent and privacy in pharmacogenetic testing Nature Genetics. ,vol. 28, pp. 207- 209 ,(2001) , 10.1038/90032

Ellen T. Matloff, Heather Shappell, Karina Brierley, Barbara A. Bernhardt, Wendy McKinnon, Beth N. Peshkin, What Would You Do? Specialists’ Perspectives on Cancer Genetic Testing, Prophylactic Surgery, and Insurance Discrimination Journal of Clinical Oncology. ,vol. 18, pp. 2484- 2492 ,(2000) , 10.1200/JCO.2000.18.12.2484

Kostas Kampourakis, Effy Vayena, Christina Mitropoulou, Ron H Schaik, David N Cooper, Joseph Borg, George P Patrinos, Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs. EMBO Reports. ,vol. 15, pp. 472- 476 ,(2014) , 10.1002/EMBR.201438641

Andrew Smart, Paul Martin, Michael Parker, Tailored medicine: Whom will it fit? The ethics of patient and disease stratification Bioethics. ,vol. 18, pp. 322- 342 ,(2004) , 10.1111/J.1467-8519.2004.00400.X

Kewal K Jain, None, Role of oncoproteomics in the personalized management of cancer Expert Review of Proteomics. ,vol. 1, pp. 49- 55 ,(2004) , 10.1586/14789450.1.1.49